期刊文献+

盐酸羟考酮控释片与芬太尼透皮贴治疗中重度癌痛的疗效比较 被引量:14

A comparison between oxycodone hydrochloride controlled-release tablets and transdermal fentanyl patch in the treatment of moderate to severe cancer pain
下载PDF
导出
摘要 目的探讨盐酸羟考酮控释片和芬太尼透皮贴治疗中重度癌痛的效果,寻找治疗中重度癌痛的有效方法。方法选取中重度癌痛患者80例,利用随机数字表法分成盐酸羟考酮控释片组40例和芬太尼透皮贴剂组40例,比较两组患者用药后的疗效及不良反应。结果盐酸羟考酮控释片组患者不良反应如恶心、呕吐、便秘不良反应发生率高于芬太尼透皮贴剂组,差异具有统计学意义(P﹤0.05);两组患者镇痛效果比较,差异无统计学意义(P﹥0.05)。结论芬太尼透皮贴在治疗中重度癌痛中能达到和盐酸羟考酮控释片相似的镇痛效果,且不良反应发生率低于盐酸羟考酮控释片,安全性较好,可作为治疗中重度癌痛的方案之一。 Objective To investigate and evaluate the efficacy of oxycodone hydrochloride controlled-release tablets and transdermal fentanyl patch in the treatment of moderate to severe cancer pain. Method 80 cases with moderate to se-vere cancer pain were enrolled in this study, and were randomized into either study group (n=40) or control group (n=40), administered with oxycodone hydrochloride controlled-release tablets or transdermal fentanyl patch respectively, accord-ing to a random number table;After medication, the efficacy and adverse reactions were compared. Result Adverse reac-tions such as nausea, vomiting, constipation were higher in study group than in control group, with significant difference observed (P〈0.05);While the analgesic effect of the two therapies were similar (P〉0.05). Conclusion Transdermal fen-tanyl patch has similar analgesic effect with oxycodone hydrochloride controlled-release tablets in treating moderate to se-vere cancer pain, with less adverse reactions at the same time, making it a safe and applicable option in the treatment of moderate to severe cancer pain.
出处 《癌症进展》 2016年第6期575-577,共3页 Oncology Progress
关键词 盐酸羟考酮控释片 芬太尼透皮贴 癌痛 疗效 oxycodone hydrochloride controlled-release tablets transdermal fentanyl patch cancer pain efficacy
  • 相关文献

参考文献12

  • 1Smith EM, Bridges CM, Kanzawa G, et al. Cancer treat- ment- related neuropathic pain syndromes-epidemiology and treatment: an update[J]. Curr Pain Headache Rep, 2014, 18(11): 459. 被引量:1
  • 2Brown MR, Ramirez JD, Farquhar-Smith E Pain in cancer survivors[J]. Br J Pain, 2014, 8(4): 139-153. 被引量:1
  • 3Jabson JM, Bowen DJ. How do follow-up care instructions and treatment summaries relate to cancer survivors' cancer- related pain?[J]. J Pain Symptom Manage, 2014, 48(6): 1247-1253. 被引量:1
  • 4侯俊平,胡敏,毛伯根,陈琦,张敏.芬太尼透皮贴剂和盐酸吗啡缓释片治疗中重度癌痛的疗效比较[J].中国实用医药,2014,9(11):184-185. 被引量:8
  • 5Torresan MM, Garrino L, Borraccino A, et al. Adherence to treatment in patient with severe cancer pain: A qualitative enquiry through illness narratives[J]. Eur J Oncol Nurs, 2015, 19(4): 397-404. 被引量:1
  • 6Lee SC, Park KS, Moon JY, et al. An exploratory study on the effectiveness of "Calmare therapy" in patients with can- cer-related neuropathic pain: A pilot study[J]. Eur J Oncol Nurs, 2016, 21: 1-7. 被引量:1
  • 7Ono H, Nakamura A, Kanemasa T, et al. Effect of estrogen on morphine- and oxycodone-induced antinociception in a female femur bone cancer pain model[J]. Eur J Pharmacol,2016, 773: 1-12. 被引量:1
  • 8Riley J, Branford R, Droney J, et al. Morphine or oxycodo- ne for cancer-related pain? A randomized, open-label, con- trolled trial[J]. J Pain Symptom Manage, 2015, 49(2): 161- 172. 被引量:1
  • 9Toussaint LL, Vincent A, McAllister S J, et al. A Compari- son of Fibromyalgia Symptoms in Patients with Healthy versus Depressive, Low and Reactive Affect Balance Styles [J]. Scand J Pain, 2014, 5(3): 161-166. 被引量:1
  • 10Gaudette F, Sirhan-Daneau A, St-Onge M, et al. Develop- ment of a sensitive method for the determination of oxyco- done and its major metabolites noroxycodone and oxymor- phone in human plasma by liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2016, 1008: 174-180. 被引量:1

二级参考文献3

共引文献7

同被引文献98

引证文献14

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部